Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1014-1023, doi:10.1016/j.jacc.2009.06.010
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Leor, J.
Right arrow Articles by Cohen, S.
PubMed
Right arrow Articles by Leor, J.
Right arrow Articles by Cohen, S.
Related Collections
Right arrowRelated Article

PRE-CLINICAL RESEARCH

Intracoronary Injection of In Situ Forming Alginate Hydrogel Reverses Left Ventricular Remodeling After Myocardial Infarction in Swine

Jonathan Leor, MD*,1, Shmuel Tuvia, PhD{dagger}, Victor Guetta, MD*, Ferenc Manczur, PhD, DVM{ddagger}, David Castel, DVM*, Udi Willenz, DVM*, Örs Petneházy, DVM§, Natali Landa, PhD*, Micha S. Feinberg, MD*, Eli Konen, MD||, Orly Goitein, MD||, Orna Tsur-Gang, PhD, Mazal Shaul, PhD{dagger}, Lea Klapper, PhD{dagger} and Smadar Cohen, PhD,2

* Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel
{dagger} BiolineRx, Jerusalem, Israel
{ddagger} Department of Internal Medicine Faculty of Veterinary Science Szent István University, Budapest, Hungary
§ Institute of Diagnostic Imaging and Radiation Oncology Kaposvár University, Kaposvár, Hungary
|| Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, Israel
Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Manuscript received October 24, 2008; revised manuscript received April 17, 2009, accepted June 2, 2009.

1 Reprint requests and correspondence: Dr. Jonathan Leor, Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer 52621, Israel (Email: leorj{at}post.tau.ac.il).

2 Dr. Smadar Cohen, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel (Email: scohen{at}bgu.ac.il).

Objectives: This study sought to determine whether alginate biomaterial can be delivered effectively into the infarcted myocardium by intracoronary injection to prevent left ventricular (LV) remodeling early after myocardial infarction (MI).

Background: Although injectable biomaterials can improve infarct healing and repair, the feasibility and effectiveness of intracoronary injection have not been studied.

Methods: We prepared a calcium cross-linked alginate solution that undergoes liquid to gel phase transition after deposition in infarcted myocardium. Anterior MI was induced in swine by transient balloon occlusion of left anterior descending coronary artery. At 4 days after MI, either alginate solution (2 or 4 ml) or saline was injected selectively into the infarct-related coronary artery. An additional group (n = 19) was treated with incremental volumes of biomaterial (1, 2, and 4 ml) or 2 ml saline and underwent serial echocardiography studies.

Results: Examination of hearts harvested after injection showed that the alginate crossed the infarcted leaky vessels and was deposited as hydrogel in the infarcted tissue. At 60 days, control swine experienced an increase in left ventricular (LV) diastolic area by 44%, LV systolic area by 45%, and LV mass by 35%. In contrast, intracoronary injection of alginate (2 and 4 ml) prevented and even reversed LV enlargement (p < 0.01). Post-mortem analysis showed that the biomaterial (2 ml) increased scar thickness by 53% compared with control (2.9 ± 0.1 mm vs. 1.9 ± 0.3 mm; p < 0.01) and was replaced by myofibroblasts and collagen.

Conclusions: Intracoronary injection of alginate biomaterial is feasible, safe, and effective. Our findings suggest a new percutaneous intervention to improve infarct repair and prevent adverse remodeling after reperfused MI.

Key Words: biomaterials • heart failure • myocardial infarction • remodeling

Abbreviations and Acronyms
  CT = computed tomography
  ECG = electrocardiogram/electrocardiographic
  ECM = extracellular matrix
  LAD = left anterior descending
  LV = left ventricle/ventricular
  MI = myocardial infarction
  MPG = myocardial perfusion grade
  MR = mitral regurgitation
  TFG = Thrombolysis In Myocardial Infarction flow grade
  TIMI = Thrombolysis In Myocardial Infarction


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement